NK and TIL Cell Expansion Reagents (K562 Feeder Cells)
NK and TIL Cell Expansion Reagents (K562 Feeder Cells)
Hillgene's NK and TIL Cell Expansion Reagent (Feeder cell) is an irradiated and inactivated engineered k562 cells expressing IL-21 and other cytokines, which, together with the mainstream immune cell culture medium, can activate and expand NK cells and tumor-infiltrating TIL cells derived from umbilical cord blood and peripheral blood mononuclear cells cultured in vitro, and the purity of the obtained NK and TIL cells is high.
Features of NK and TIL Cell Expansion Reagents (K562 Feeder Cells)
Reliability
Reliable NK,TIL expansion using K562 feeder system
Results
NK and TIL expansion reagents with K562 feeder
Efficiency
K562 feeder reagents for efficient NK and TIL growth
NK Cell Preparation Flowchart
D0: Plasma and PBMC isolation, inoculation and activation
D4: Observe and medium exchange
D6: Observe and medium infusion
D8: Observe and medium infusion, re-activation
D10: Observe and medium exchange
D12: Observe and medium infusion
D14: Harvest
Application of NK and TIL Cell Expansion Reagents (K562 Feeder Cell)
Suitable for activation and mass expansion of different immune cells such as NK cells, CAR-NK cells and TIL.
Process Development Stage: Evaluate the in vitro expansion capacity of cells such as NK and TIL and optimize the process during the early development stage of cell therapy products.
Process locking, product production and comparability study phase: During the mid-term process locking, production and cell process change phase after IND approval for cell therapy products, establish stable cell expansion processes based on trophoblast cells, such as NK and TIL, and carry out process locking, cellular drug production and comparability studies for cell products.
Hillgene provides full-service CDMO solutions for CAR-T, CAR-NK, and TCR-T therapies, supporting your journey from research to GMP manufacturing and beyond. As a specialized cell therapy biopharma CDMO, we offer expertise in CAR-T manufacturing, viral vector production, and regulatory support. Our agile team helps biotechs accelerate development with flexible, scalable, and compliant processes. Whether you're entering clinical trials or preparing for commercialization, our customized approach ensures speed, quality, and reliability at every stage. Partner with us to bring your next-generation therapies to life, faster and smarter.

评论
发表评论